𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma

✍ Scribed by Wenzel, Sally E.; Barnes, Peter J.; Bleecker, Eugene R.; Bousquet, Jean; Busse, William; Dahlén, Sven-Erik; Holgate, Stephen T.; Meyers, Deborah A.; Rabe, Klaus F.; Antczak, Adam; Baker, James; Horvath, Ildiko; Mark, Zsuzsanna; Bernstein, David; Kerwin, Edward; Schlenker-Herceg, Rozsa; Lo, Kim Hung; Watt, Rosemary; Barnathan, Elliot S.; Chanez, Pascal

Book ID
120823518
Publisher
American Thoracic Society
Year
2009
Tongue
English
Weight
350 KB
Volume
179
Category
Article
ISSN
1073-449X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of tumor necrosis factor blockad
Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study
✍ Naveed Sattar; Philippa Crompton; Lynne Cherry; David Kane; Gordon Lowe; Iain B. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective To conduct a robust, double‐blind, placebo‐controlled study examining the effects of tumor necrosis factor (TNF) modulation on concentrations of traditional and novel cardiovascular disease risk factors in patients with an inflammatory condition. ## Methods In this doubl

Randomized double-blind comparison of ch
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
✍ Filip Van den Bosch; Elli Kruithof; Dominique Baeten; Annemie Herssens; Filip de 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## Objective To confirm in a placebo‐controlled trial the safety and efficacy profile of infliximab in short‐term treatment of patients with active spondylarthropathy (SpA). ## Methods Forty patients with active SpA were randomly assigned to receive an intravenous loading dose (weeks